139 related articles for article (PubMed ID: 12746839)
21. Tyrosine kinase inhibitor as a novel signal transduction and antiproliferative agent: prostate cancer.
Kondapaka BS; Reddy KB
Mol Cell Endocrinol; 1996 Mar; 117(1):53-8. PubMed ID: 8734473
[TBL] [Abstract][Full Text] [Related]
22. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).
Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC
Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027
[TBL] [Abstract][Full Text] [Related]
23. Low androgen sensitivity is associated with low levels of Akt phosphorylation in LNCaP-E9 cells.
Iguchi K; Fukami K; Ishii K; Otsuka T; Usui S; Sugimura Y; Hirano K
J Androl; 2012; 33(4):660-6. PubMed ID: 22016349
[TBL] [Abstract][Full Text] [Related]
24. Regulation of apoptosis by androgens in prostate cancer cells.
Arnoldussen YJ; Wang L; Saatcioglu F
Methods Mol Biol; 2011; 776():349-60. PubMed ID: 21796536
[TBL] [Abstract][Full Text] [Related]
25. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP.
Wang QF; Tilly KI; Tilly JL; Preffer F; Schneyer AL; Crowley WF; Sluss PM
Endocrinology; 1996 Dec; 137(12):5476-83. PubMed ID: 8940374
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
27. Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling.
Oosterhoff JK; Grootegoed JA; Blok LJ
Endocr Relat Cancer; 2005 Mar; 12(1):135-48. PubMed ID: 15788645
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor-induced neuroendocrine differentiation and apoptotic resistance of androgen-independent human prostate cancer cells.
Humez S; Monet M; Legrand G; Lepage G; Delcourt P; Prevarskaya N
Endocr Relat Cancer; 2006 Mar; 13(1):181-95. PubMed ID: 16601287
[TBL] [Abstract][Full Text] [Related]
29. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells.
Lee MS; Igawa T; Lin MF
Oncogene; 2004 Apr; 23(17):3048-58. PubMed ID: 14990987
[TBL] [Abstract][Full Text] [Related]
31. ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells.
Lee MS; Igawa T; Yuan TC; Zhang XQ; Lin FF; Lin MF
Oncogene; 2003 Feb; 22(5):781-96. PubMed ID: 12569372
[TBL] [Abstract][Full Text] [Related]
32. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation.
Kokontis J; Takakura K; Hay N; Liao S
Cancer Res; 1994 Mar; 54(6):1566-73. PubMed ID: 7511045
[TBL] [Abstract][Full Text] [Related]
33. Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines.
Pignon JC; Koopmansch B; Nolens G; Delacroix L; Waltregny D; Winkler R
Cancer Res; 2009 Apr; 69(7):2941-9. PubMed ID: 19318561
[TBL] [Abstract][Full Text] [Related]
34. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
Guillemette C; Hum DW; Bélanger A
Endocrinology; 1996 Jul; 137(7):2872-9. PubMed ID: 8770908
[TBL] [Abstract][Full Text] [Related]
35. Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor.
Liu XH; Wiley HS; Meikle AW
J Clin Endocrinol Metab; 1993 Dec; 77(6):1472-8. PubMed ID: 8263129
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic targeting of multiple signaling pathways in malignant pleural mesothelioma.
Mukohara T; Civiello G; Johnson BE; Janne PA
Oncology; 2005; 68(4-6):500-10. PubMed ID: 16020981
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells.
Lu S; Tsai SY; Tsai MJ
Endocrinology; 1999 Nov; 140(11):5054-9. PubMed ID: 10537131
[TBL] [Abstract][Full Text] [Related]
38. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
39. Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response.
Soto AM; Lin TM; Sakabe K; Olea N; Damassa DA; Sonnenschein C
Oncol Res; 1995; 7(10-11):545-58. PubMed ID: 8866667
[TBL] [Abstract][Full Text] [Related]
40. Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP.
Schuurmans AL; Bolt J; Mulder E
Prostate; 1988; 12(1):55-63. PubMed ID: 3258066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
